or Try an Advanced Search...

    Technical Analysis for ME - 23andMe Holding Co.

    Grade Last Price % Change Price Change
    F 0.38 -3.83% -0.02
    ME closed down 3.83 percent on Monday, July 1, 2024, on 1.36 times normal volume.
    5 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ME trend table...
    Date Alert Name Type % Chg
    MACD Bearish Signal Line Cross Bearish 0.00%
    20 DMA Resistance Bearish -3.83%
    Volume Surge Other -3.83%
    Outside Day Range Expansion -3.83%
    Wide Bands Range Expansion -3.83%
    Pocket Pivot Bullish Swing Setup -11.13%
    Wide Bands Range Expansion -11.13%
    Gapped Up Strength -11.13%
    20 DMA Resistance Bearish -6.42%
    180 Bearish Setup Bearish Swing Setup -6.42%
    Older End-of-Day Signals for ME ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 4 hours ago
    Down 2 % about 8 hours ago
    60 Minute Opening Range Breakdown about 8 hours ago
    Fell Below Previous Day's Low about 9 hours ago
    Down 1% about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ME Chart by TradingView
    Basic chart:

    Profile

    23andMe, Inc., a consumer genetics and research company, engages in developing a genetic database to unlock insights leading to the rapid discovery of new targets for drug development. It offers a crowdsourced platform that helps people to access, understand, and benefit from the human genome; access direct-to-consumer genetic testing; and give consumers personalized information about their genetic health risks, ancestry, and traits. The company was incorporated in 2006 and is based in Sunnyvale, California with an additional office in Mountain View, California.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Biology Genetics Genomics Drug Development Medical Genetics Applied Genetics Genetic Testing Human Genome

    Is ME a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 28 23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
    Jun 11 3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition
    Jun 5 23andMe Launches New Genetic Report on Bipolar Disorder
    Jun 4 Why 23andMe Stock Tumbled 10% on Tuesday
    Jun 4 23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black Community
    Jun 3 23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting
    May 29 Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history
    May 25 23andMe Holding Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
    May 24 Q4 2024 23andMe Holding Co. Earnings Call
    May 23 23andMe Holding Co. (ME) Q4 2024 Earnings Call Transcript
    See more ME news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.03
    52 Week Low 0.35
    Average Volume 5,174,928
    200-Day Moving Average 0.68
    50-Day Moving Average 0.48
    20-Day Moving Average 0.42
    10-Day Moving Average 0.41
    Average True Range 0.04
    RSI (14) 35.90
    ADX 15.62
    +DI 14.90
    -DI 21.79
    Chandelier Exit (Long, 3 ATRs) 0.50
    Chandelier Exit (Short, 3 ATRs) 0.49
    Upper Bollinger Bands 0.48
    Lower Bollinger Band 0.36
    Percent B (%b) 0.15
    BandWidth 29.73
    MACD Line -0.03
    MACD Signal Line -0.02
    MACD Histogram -0.0007
    Fundamentals Value
    Market Cap 118.67 Million
    Num Shares 315 Million
    EPS -1.11
    Price-to-Earnings (P/E) Ratio -0.34
    Price-to-Sales 1.21
    Price-to-Book 0.81
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.43
    Resistance 3 (R3) 0.43 0.42 0.42
    Resistance 2 (R2) 0.42 0.41 0.42 0.41
    Resistance 1 (R1) 0.40 0.40 0.39 0.39 0.41
    Pivot Point 0.39 0.39 0.38 0.38 0.39
    Support 1 (S1) 0.36 0.37 0.36 0.36 0.34
    Support 2 (S2) 0.35 0.37 0.35 0.34
    Support 3 (S3) 0.33 0.35 0.33
    Support 4 (S4) 0.33